Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients

被引:94
作者
Broedbaek, Kasper [1 ,2 ]
Siersma, Volkert [3 ,4 ]
Henriksen, Trine [1 ,2 ]
Weimann, Allan [1 ,2 ]
Petersen, Morten [1 ,2 ]
Andersen, Jon T. [1 ,2 ]
Jimenez-Solem, Espen [1 ,2 ]
Stovgaard, Elisabeth S. [1 ,2 ]
Hansen, Lars J. [3 ,4 ]
Henriksen, Jan Erik [5 ]
Bonnema, Steen J. [5 ]
Olivarius, Niels de Fine [3 ,4 ]
Poulsen, Henrik E. [1 ,2 ,6 ]
机构
[1] Rigshosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark
[2] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark
[3] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark
[4] Univ Copenhagen, Sect Gen Practice, Dept Publ Hlth, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
[6] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
COMPLICATIONS; INSIGHTS; STRESS;
D O I
10.2337/dc11-1620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-We analyzed data from a cohort of 1,381 newly diagnosed type 2 diabetic patients to test the hypothesis that urinary markers of nucleic acid oxidation are independent predictors of mortality. RESEARCH DESIGN AND METHODS-We examined the relationship between urinary excretion of markers of DNA oxidation (8-oxo-7,8-dihydro-2'-deoxyguanosine [8-oxodG]) and RNA oxidation (8-oxo-7,8-dihydroguanosine [8-oxoGuol) and long-term mortality using Cox proportional hazards regression. RESULTS-After multivariate adjustment, the hazard ratios for all-cause and diabetes-related mortality of patients with 8-oxoGuo levels in the highest quartile compared with those in the lowest quartile were 1.44(1.12-1.85) and 1.54(1.13-2.10), respectively. Conversely, no significant associations between 8-oxodG and mortality were found in the adjusted analyses. CONCLUSIONS-Urinary excretion of the RNA oxidation marker 8-oxoGuo measured shortly after diagnosis of type 2 diabetes predicts long-term mortality independently of conventional risk factors. This finding suggests that 8-oxoGuo could serve as a new clinical biomarker in diabetes.
引用
收藏
页码:2594 / 2596
页数:3
相关论文
共 11 条
[1]   Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes [J].
Broedbaek, Kasper ;
Weimann, Allan ;
Stovgaard, Elisabeth S. ;
Poulsen, Henrik E. .
FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (08) :1473-1479
[2]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[3]   Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials [J].
Calcutt, Nigel A. ;
Cooper, Mark E. ;
Kern, Tim S. ;
Schmidt, Ann Marie .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) :417-429
[4]   New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy [J].
Ceriello, A .
DIABETES CARE, 2003, 26 (05) :1589-1596
[5]   Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2′-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry [J].
Henriksen, Trine ;
Hillestrom, Peter R. ;
Poulsen, Henrik E. ;
Weimann, Allan .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (05) :629-635
[6]  
Juel K, 1999, DAN MED BULL, V46, P354
[7]   Urinary biomarkers involved in type 2 diabetes: a review [J].
Matheson, Agnes ;
Willcox, Mark D. P. ;
Flanagan, Judith ;
Walsh, Bradley J. .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (03) :150-171
[8]   Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies [J].
Mazzone, Theodore ;
Chait, Alan ;
Plutzky, Jorge .
LANCET, 2008, 371 (9626) :1800-1809
[9]   Randomised controlled trial of structured personal care of type 2 diabetes mellitus [J].
Olivarius, ND ;
Beck-Nielsen, H ;
Andreasen, AH ;
Horder, M ;
Pedersen, PA .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7319) :970-975
[10]  
Pedersen CB, 2006, DAN MED BULL, V53, P441